ShangPharma Innovation

ShangPharma Innovation is a global innovation incubator and investment organization dedicated to accelerating drug discovery and development, with a particular emphasis on therapeutics and technology platforms. The firm offers funding, incubator space, and other support to its ecosystem of collaborators, partners, and tenants, including sponsoring proof-of-concept research at major academic and medical centers, research institutes, and seed-stage start-ups. This approach aims to bridge the gap between academic research and industrial development, facilitating the advancement of promising life science inventions.

The firm collaborates closely with scientific founders to achieve development milestones efficiently, emphasizing a growth-minded and founder-centric approach. By providing funding, scientific expertise, and operational support, ShangPharma Innovation transforms promising early-stage concepts into successful companies. The firm values the long-term, active involvement of scientific founders and excels in advancing novel therapeutics through critical development phases and into clinical application.

ShangPharma Innovation has engaged in strategic collaborations with institutions such as the University of California, San Francisco (UCSF) and SRI International to accelerate the development of promising life science inventions. These partnerships involve funding and supporting preclinical research to validate drug targets and develop programs to discover new drugs, with the goal of advancing these candidates toward clinical trials. Through these collaborations, ShangPharma Innovation demonstrates its commitment to bridging the gap between academic research and industrial development, facilitating the advancement of promising life science inventions.